Showing 1 - 9 results of 9 for search 'Laura Sighinolfi', query time: 0.04s Refine Results
  1. 1
    A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study

    A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study by Martina Maritati, Trentini Alessandro, Nunzia Zanotta, Manola Comar, Tiziana Bellini, Laura Sighinolfi, Carlo Contini

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

    Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation by Mario Luca Morieri, Viola Guardigni, Juana Maria Sanz, Edoardo Dalla Nora, Cecilia Soavi, Giovanni Zuliani, Laura Sighinolfi, Angelina Passaro

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Increasing clinical virulence in two decades of the Italian HIV epidemic.

    Increasing clinical virulence in two decades of the Italian HIV epidemic. by Viktor Müller, Franco Maggiolo, Fredy Suter, Nicoletta Ladisa, Andrea De Luca, Andrea Antinori, Laura Sighinolfi, Eugenia Quiros-Roldan, Giampiero Carosi, Carlo Torti

    Published 2009-05-01
    Get full text
    Article
  4. 4
    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.

    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART. by Giuseppe Lapadula, Liliane Chatenoud, Andrea Gori, Francesco Castelli, Simona Di Giambenedetto, Massimiliano Fabbiani, Franco Maggiolo, Emanuele Focà, Nicoletta Ladisa, Laura Sighinolfi, Massimo Di Pietro, Angelo Pan, Carlo Torti, Italian MASTER Cohort

    Published 2015-01-01
    Get full text
    Article
  5. 5
    The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

    The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: result... by Elena Raffetti, Maria Concetta Postorino, Francesco Castelli, Salvatore Casari, Filippo Castelnuovo, Franco Maggiolo, Elisa Di Filippo, Alessandro D’Avino, Andrea Gori, Nicoletta Ladisa, Massimo Di Pietro, Laura Sighinolfi, Fabio Zacchi, Carlo Torti

    Published 2016-08-01
    Get full text
    Article
  6. 6
    Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.

    Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. by Daria Gotti, Elena Raffetti, Laura Albini, Laura Sighinolfi, Franco Maggiolo, Elisa Di Filippo, Nicoletta Ladisa, Gioacchino Angarano, Giuseppe Lapadula, Angelo Pan, Anna Degli Esposti, Massimiliano Fabbiani, Emanuele Focà, Alfredo Scalzini, Francesco Donato, Eugenia Quiros-Roldan, Master Cohort Group

    Published 2014-01-01
    Get full text
    Article
  7. 7
    Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment.

    Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment. by Giuseppe Lapadula, Davide Paolo Bernasconi, Salvatore Casari, Franco Maggiolo, Roberto Cauda, Massimo Di Pietro, Nicoletta Ladisa, Laura Sighinolfi, Sarah Dal Zoppo, Francesca Sabbatini, Alessandro Soria, Chiara Pezzoli, Annalisa Mondi, Silvia Costarelli, Maria Grazia Valsecchi, Carlo Torti, Andrea Gori, Italian MASTER cohort

    Published 2016-01-01
    Get full text
    Article
  8. 8
    Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

    Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study by Cecilia Sgadari, Paolo Monini, Antonella Tripiciano, Orietta Picconi, Anna Casabianca, Chiara Orlandi, Sonia Moretti, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia, Massimo Campagna, Stefania Bellino, Marianna Meschiari, Silvia Nozza, Laura Sighinolfi, Alessandra Latini, Antonio Muscatello, Annalisa Saracino, Massimo Di Pietro, Massimo Galli, Aurelio Cafaro, Mauro Magnani, Fabrizio Ensoli, Barbara Ensoli

    Published 2019-02-01
    Get full text
    Article
  9. 9
    Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

    Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. by Barbara Ensoli, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Vittorio Francavilla, Simone Marcotullio, Aurelio Cafaro, Orietta Picconi, Giovanni Paniccia, Arianna Scoglio, Angela Arancio, Cristina Ariola, Maria J Ruiz Alvarez, Massimo Campagna, Donato Scaramuzzi, Cristina Iori, Roberto Esposito, Cristina Mussini, Florio Ghinelli, Laura Sighinolfi, Guido Palamara, Alessandra Latini, Gioacchino Angarano, Nicoletta Ladisa, Fabrizio Soscia, Vito S Mercurio, Adriano Lazzarin, Giuseppe Tambussi, Raffaele Visintini, Francesco Mazzotta, Massimo Di Pietro, Massimo Galli, Stefano Rusconi, Giampiero Carosi, Carlo Torti, Giovanni Di Perri, Stefano Bonora, Fabrizio Ensoli, Enrico Garaci

    Published 2010-11-01
    Get full text
    Article

Search Tools: